Cite
HARVARD Citation
Ghofrani, H. et al. (2016). Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial. Lancet. 4 (5), pp. 361-371. [Online].